Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Chronic Myeloid Leukemia

Welcome to the Cancer Connect Leukemia Resource Center and Community. Our goal is to bring patients, caregivers, advocates and experts together in a single community where individuals benefit from expert-authored news and educational programming alongside a robust social network.

  • FDA Approves Scemblix for Chronic Myeloid Leukemia First-Line Treatment
    November 7, 2024

    FDA Approves Scemblix for Chronic Myeloid Leukemia First-Line Treatment

    Dr. C H Weaver MD
  • STAMP Inhibitor Scemblix for CML
    February 10, 2021

    STAMP Inhibitor Scemblix for CML

    Dr. C H Weaver MD
  • Ask the Expert: Chronic Myeloid Leukemia
    June 19, 2020

    Ask the Expert: Chronic Myeloid Leukemia

    Dr. C H Weaver MD
  • Gleevec® for CML: Long-lasting Anticancer Responses Confirmed
    March 13, 2020

    Gleevec® for CML: Long-lasting Anticancer Responses Confirmed

    Dr. C H Weaver MD
  • Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia
    March 6, 2020

    Iclusig (ponatinib) Treatment of Chronic Myelod Leukemia

    Dr. C H Weaver MD
  • Chronic Myeloid Leukemia
    March 6, 2020

    Chronic Myeloid Leukemia

    Dr. C H Weaver MD
  • Bosulif (bosutinib) Treatment of Chronic Myelogenous Leukemia
    March 6, 2020

    Bosulif (bosutinib) Treatment of Chronic Myelogenous Leukemia

    Dr. C H Weaver MD
  • Tasigna® (nilotinib) Treatment for Chronic Myeloid Leukemia
    March 6, 2020

    Tasigna® (nilotinib) Treatment for Chronic Myeloid Leukemia

    Dr. C H Weaver MD
  • Sprycel® Therapy for Chronic Myeloid Leukemia
    March 6, 2020

    Sprycel® Therapy for Chronic Myeloid Leukemia

    Dr. C H Weaver MD
  • Could Flumatinib Replace Gleevec in Chronic-Phase Chronic Myeloid Leukemia?
    August 31, 2019

    Could Flumatinib Replace Gleevec in Chronic-Phase Chronic Myeloid Leukemia?

    Dr. C H Weaver MD
  • Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
    May 7, 2019

    Two Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML

    Dr. C H Weaver MD
  • Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia
    May 3, 2019

    Understanding TKI Therapy and Drug Resistance in Chronic Myelogenous Leukemia

    Dr. C H Weaver MD
1 2
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...